Despite the importance of MEF2C-MYOCD modulation in SMC phenotype switching, incomplete knowledge of MEF2C, MYOCD and SMC-specific proteins in PAH limits our understanding of the underlying mechanisms controlling differentiation. The gene discussed is MEF2C; the disease is pulmonary arterial hypertension.